ANTIDEPRESSANT: Owosso man judged incompetent to stand trial

CORUNNA –
The 33-year-old Owosso man accused of two Sept. 11 murders was found incompetent
to stand trial and will be remanded to the State Department of Mental Health for
treatment.

Sixty-sixth District Court Judge Terrance P. Dignan signed an
order Wednesday afternoon finding Harlan Drake incompetent. However, Dignan, in
his written opinion, said there is a substantial probability Drake will attain
competence with treatment.

Dignan’s decision was based on a report filed
by the Center for Forensic Psychiatry in Ann Arbor, where Drake was
evaluated.

Read More

ANTIDEPRESSANT: Mother of Columbine killer tells of horror 10 yrs after massacre

The
mother of one of the two teenagers who murdered a dozen fellow students and a
teacher in the massacre at Columbine high school has broken a decade of

silence to say that she is unable to look at another child without thinking
about the horror and suffering her son caused.

Susan
Klebold, whose son Dylan and another youth, Eric Harris, hunted down pupils at
the Colorado school with shotguns, a semi-automatic pistol and a rifle before
killing themselves, has described her trauma over her son’s actions.

Read More

4/28/2001 – A Prescription for Violence? (School Shootings)

Ronald Stephens, executive director of the National School Safety
Center says: Its the thought that if youre going to put Charlie Manson in my
class I have a right to know that. . . We have kids so medicated its
incredible. I dont see parents asking the question about the numbers of
children on psychotropic drugs as being all that invasive. The public would
be shocked at the number of file drawers of prescription drugs that teachers
are asked to dispense. . . . it would be a great study for someone to go back
and see how many of the kids who committed these violent acts were on these
drugs.

Read More

4/18/2001 – Paxil Is Approved for Anxiety Disorder?!

WASHINGTON, April 16 (Bloomberg News) — Glaxo- SmithKline P.L.C. has won the
Food and Drug Administration’s approval to market its antidepressant Paxil
for treating general anxiety disorder, a new use for the drug.

That makes Paxil the first drug in its class to be approved for the
condition, which affects about 10 million Americans and involves excessive,
often debilitating worrying, the company said today.

Read More